Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression

BackgroundType 2 diabetes mellitus (T2DM) is a complex systemic disease, with significant disorders of metabolism. The liver, a central energy metabolic organ, plays a critical role in the development of diabetes. Although gene expression levels are able to be measured via microarray since 1996, it is difficult to evaluate the contributions of one altered gene expression to a specific disease. One of the reasons is that a whole network picture responsible for a specific phase of diabetes is missing, while a single gene has to be put into a network picture to evaluate its importance. In the aim of identifying significant transcriptional regulatory networks in the liver contributing to diabetes, we have performed comprehensive active regulatory network survey by network screening in 4 weeks (w), 8-12 w, and 18-20 w Goto-Kakizaki (GK) rat liver microarray data.ResultsWe identify active regulatory networks in GK rat by network screening in the following procedure. First, the regulatory networks are compiled by using the known binary relationships between the transcriptional factors and their regulated genes and the biological classification scheme, and second, the consistency of each regulatory network with the microarray data measured in GK rat is estimated to detect the active networks under the corresponding conditions. The comprehensive survey of the consistency between the networks and the measured data by the network screening approach in the case of non-insulin dependent diabetes in the GK rat reveals: 1. More pathways are active during inter-middle stage diabetes; 2. Inflammation, hypoxia, increased apoptosis, decreased proliferation, and altered metabolism are characteristics and display as early as 4weeks in GK strain; 3. Diabetes progression accompanies insults and compensations; 4. Nuclear receptors work in concert to maintain normal glycemic robustness system.ConclusionNotably this is the first comprehensive network screening study of non-insulin dependent diabetes in the GK rat based on high throughput data of the liver. Several important pathways have been revealed playing critical roles in the diabetes progression. Our findings also implicate that network screening is able to help us understand complex disease such as diabetes, and demonstrate the power of network systems biology approach to elucidate the essential mechanisms which would escape conventional single gene-based analysis.

[1]  D. Saini,et al.  Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals , 2009, BMC Medical Genetics.

[2]  Edgar Wingender,et al.  The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation , 2008, Briefings Bioinform..

[3]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[4]  M. Permutt,et al.  Genetic epidemiology of diabetes. , 2005, The Journal of clinical investigation.

[5]  J. Huttunen,et al.  Postheparin Plasma Lipoprotein Lipase and Hepatic Lipase in Diabetes Mellitus: Relationship to Plasma Triglyceride Metabolism , 1977, Diabetes.

[6]  Gareth Griffiths,et al.  Lysosomal Enzyme Trafficking between Phagosomes, Endosomes, and Lysosomes in J774 Macrophages , 1998, The Journal of Biological Chemistry.

[7]  Claes Ohlsson,et al.  SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.

[8]  J. Auwerx,et al.  Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus , 1988, Arteriosclerosis.

[9]  Kazuyuki Aihara,et al.  Modeling Biomolecular Networks in Cells , 2010 .

[10]  R A Roth,et al.  Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. , 1994, Molecular endocrinology.

[11]  Debra C DuBois,et al.  Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. , 2009, The Journal of endocrinology.

[12]  Jeff Kuret,et al.  Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis , 2008, Neuroscience Letters.

[13]  A. Dobs,et al.  Androgen deficiency, diabetes, and the metabolic syndrome in men , 2007, Current opinion in endocrinology, diabetes, and obesity.

[14]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[15]  Marion Hetherington,et al.  Gene-environment interactions in obesity. , 2010, Forum of nutrition.

[16]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[17]  A. Thorburn,et al.  Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds? , 1995, Australian and New Zealand journal of medicine.

[18]  Philippe Froguel,et al.  Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat , 1996, Nature Genetics.

[19]  Luonan Chen,et al.  Biomolecular Networks: Methods and Applications in Systems Biology , 2009 .

[20]  Simon Smyth,et al.  Diabetes and obesity: the twin epidemics , 2006, Nature Medicine.

[21]  Luc Pénicaud,et al.  Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. , 2010, Journal of Clinical Investigation.

[22]  H. Luthman,et al.  Pathophysiological and genetic characterization of the major diabetes locus in GK rats. , 1999, Diabetes.

[23]  Luonan Chen,et al.  Multi-equilibrium property of metabolic networks: SSI module , 2011, Proceedings of the 30th Chinese Control Conference.

[24]  A. Fornace,et al.  ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth , 2002, Oncogene.

[25]  Zsuzsanna Bereczky,et al.  Fibrin Stabilization (Factor XIII), Fibrin Structure and Thrombosis , 2003, Pathophysiology of Haemostasis and Thrombosis.

[26]  Kazuyuki Aihara,et al.  Modeling Biomolecular Networks in Cells: Structures and Dynamics , 2010 .

[27]  Albert K Groen,et al.  Genetic background of cholesterol gallstone disease. , 2003, Biochimica et biophysica acta.

[28]  Judea Pearl,et al.  Probabilistic reasoning in intelligent systems , 1988 .

[29]  B. Bravenboer,et al.  Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity‐onset diabetes of the young , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[30]  W. Soeller,et al.  Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. , 2002, Diabetes.

[31]  M. Hayden,et al.  Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. , 2002, JOP : Journal of the pancreas.

[32]  Hong Zhu,et al.  Evidence that a West-East admixed population lived in the Tarim Basin as early as the early Bronze Age , 2010, BMC Biology.

[33]  Oksana Gavrilova,et al.  Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. , 2003, Diabetes.

[34]  Katsuhisa Horimoto,et al.  BMC Systems Biology BioMed Central Methodology article , 2008 .

[35]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[36]  R. Jove,et al.  The Ras GTPase-activating Protein (GAP) Is an SH3 Domain-binding Protein and Substrate for the Src-related Tyrosine Kinase, Hck (*) , 1995, Journal of Biological Chemistry.

[37]  B. Yandell,et al.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Perry F. Bartlett,et al.  Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling , 2002, Nature Neuroscience.

[39]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Eric P. Smith,et al.  An Introduction to Statistical Modeling of Extreme Values , 2002, Technometrics.

[41]  Kazuko Kobayashi,et al.  The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation. , 2009, Autoimmunity reviews.